CREDIT AGREEMENT Dated as of May 11, 2010, among KING PHARMACEUTICALS, INC., THE LENDERS NAMED HEREIN, CREDIT SUISSE AG, as Administrative Agent, as Collateral Agent and as Swingline Lender, CREDIT SUISSE SECURITIES (USA) LLC, BANK OF AMERICA, N.A.,...Credit Agreement • August 9th, 2010 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2010 Company Industry JurisdictionCREDIT AGREEMENT dated as of May 11, 2010 (as further amended, supplemented or otherwise modified from time to time, this “Agreement”), among KING PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”); the Lenders (as defined in Article I); CREDIT SUISSE AG, a bank organized under the laws of Switzerland, acting through its Cayman Islands Branch, as administrative agent and collateral agent for the Lenders (in such capacities, respectively, the “Administrative Agent” and the “Collateral Agent”), and as swingline lender (in such capacity, the “Swingline Lender”), Credit Suisse Securities (USA) LLC, Bank of America, N.A., DnB NOR Bank ASA, SunTrust Bank and U.S. Bank National Association, as co-syndication agents (in such capacity, “Co-Syndication Agents”); and the Issuing Banks (as defined in Article I).
INDEMNIFICATION AGREEMENTIndemnification Agreement • August 9th, 2010 • King Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Contract Type FiledAugust 9th, 2010 Company Industry JurisdictionThis Indemnification Agreement is made this ___ day of ______, 20___, between King Pharmaceuticals, Inc., a Tennessee corporation (the “Company”), and , a director of the Company (the “Director”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • August 9th, 2010 • King Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Contract Type FiledAugust 9th, 2010 Company Industry JurisdictionThis Indemnification Agreement is made this day of , 20 , between King Pharmaceuticals, Inc., a Tennessee corporation (the “Company”), and , an officer of the Company (the “Officer”).
*** ] CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT MARKED BY BRACKETS HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES AND EXCHANGE ACT OF 1934 AS AMENDED. June 25, 2010 Mr....King Pharmaceuticals Inc • August 9th, 2010 • Pharmaceutical preparations
Company FiledAugust 9th, 2010 Industry